MicroRNAs contribute to breast cancer invasiveness

I Fridrichova, I Zmetakova - Cells, 2019 - mdpi.com
Cancer statistics in 2018 highlight an 8.6 million incidence in female cancers, and 4.2 million
cancer deaths globally. Moreover, breast cancer is the most frequent malignancy in females …

[HTML][HTML] Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancer

NM Ghahhari, S Babashah - European journal of cancer, 2015 - Elsevier
The WNT/β-catenin signalling implies its significance in maintaining an epithelial cell
phenotype, proper cell–cell junctions, and tissue homeostasis. Dysregulation of the …

Recent advances in microfluidic platforms applied in cancer metastasis: Circulating tumor cells'(CTCs) isolation and tumor‐on‐a‐chip

Z Lin, G Luo, W Du, T Kong, C Liu, Z Liu - Small, 2020 - Wiley Online Library
Cancer remains the leading cause of death worldwide despite the enormous efforts that are
made in the development of cancer biology and anticancer therapeutic treatment …

Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks

J Vaquero, N Guedj, A Clapéron… - Journal of …, 2017 - Elsevier
Cholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to its late
clinical presentation and the lack of effective non-surgical therapies. Unfortunately, most of …

[HTML][HTML] Biomarkers for EMT and MET in breast cancer: An update

F Liu, LN Gu, BE Shan, CZ Geng… - Oncology …, 2016 - spandidos-publications.com
Metastasis and recurrence are the leading cause of mortality due to breast cancer, but the
underlying mechanisms are still poorly understood. Understanding the breast cancer …

Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment

R Portillo-Lara, N Annabi - Lab on a chip, 2016 - pubs.rsc.org
More than 90% of cancer-related deaths can be attributed to the occurrence of metastatic
diseases. Recent studies have highlighted the importance of the multicellular, biochemical …

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

Y Zhao, Y Li, J Sheng, F Wu, K Li, R Huang… - Journal of Experimental …, 2019 - Springer
Background TP53 is one of the most frequently mutated genes among all cancer types, and
TP53 mutants occur more than 60% in colorectal cancer (CRC). Among all mutants, there …

Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters?

I Fridrichova, L Kalinkova, S Ciernikova - International Journal of …, 2022 - mdpi.com
Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates;
thus, early identification of metastatic features and disease recurrence through precise …

MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer

Y Lei, L Chen, G Zhang, A Shan, C Ye… - Oncology …, 2020 - spandidos-publications.com
Abstract Epithelial‑mesenchymal transition (EMT), during which cancer cells lose the
epithelial phenotype and gain the mesenchymal phenotype, has been verified to result in …

Fisetin inhibited growth and metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via PTEN/Akt/GSK3β signal pathway

J Li, X Gong, R Jiang, D Lin, T Zhou, A Zhang… - Frontiers in …, 2018 - frontiersin.org
Triple negative breast cancer (TNBC), characterized by its highly aggressive and metastatic
features, is associated with poor prognosis and high mortality partly due to lack of effective …